Medtronic (Minneapolis) said Thursday it will pay $268 million to settle U.S. lawsuits related to its Sprint Fidelis family of defibrillation leads which the company recalled three years ago. (Medical Device Daily)
It's just a wire. But to the physicians who use the newest guidewire from Boston Scientific (Natick, Massachusetts) the Journey guidewire is so much more than an ordinary wire – at least that's what the company is hoping. (Medical Device Daily)
When cancer is the enemy, the three major weapons used to fight it are surgery, chemotherapy, and radiation. If Novocure (Portsmouth, New Hampshire) has its way, a fourth major cancer treatment may soon be added to that list. (Medical Device Daily)
The standard method of screening a man for prostate cancer is to look at his prostate specific antigen (PSA) level. If his PSA level is abnormal, he may have the disease – but not necessarily. So he is usually sent to have a biopsy and roughly 60% of the time the biopsy will come back negative. (Medical Device Daily)
Calypso Medical Technologies (Seattle) has taken its radiation therapy system a step further by adding the capability to automatically turn off the radiation beam if the tumor moves out of the planned location. (Medical Device Daily)
